(Q54266940)
Statements
Phase I Clinical Trial to Determine the Feasibility and Maximum Tolerated Dose of Panitumumab to Standard Gemcitabine-Based Chemoradiation in Locally Advanced Pancreatic Cancer (English)
Annette A van Zweeden
Johanna W Wilmink
Otto W M Meijer
Anna M E Bruynzeel
Geertjan van Tienhoven
Geert Kazemier
Maarten A J M Jacobs
Henk M W Verheul